Alamar Biosciences
ALMR

Alamar Biosciences (ALMR) earnings history

Most recent quarter

Period end
Jun 30, 2026
EPS actual
−$0.22
EPS estimate
−$0.31
Revenue
$29.4M
Reported
Aug 10, 2026

Alamar Biosciences reported Q2 2026 results on August 10, 2026. It posted a loss of $0.22 per share, narrower than the estimated $0.31 loss, a 28.55% beat. Revenue was $29.4 million, 13.69% above the $25.9 million estimate.

The record is short. The table holds only two quarters, so there is no year-earlier quarter to compare with and no full year to total. In Q1 2026, reported May 8, 2026, Alamar lost $1.74 per share, slightly worse than the $1.71 loss expected, on revenue of $26.0 million that matched its estimate. From Q1 to Q2, revenue rose and the loss per share narrowed sharply. Both quarters in the table were losses, adding up to $1.96 per share for the first half of 2026.

The two reports came 94 days apart. If the company keeps a quarterly rhythm, Q3 2026 results would follow around early-to-mid November 2026. With so little history, the next report will be the first chance to see whether the narrower loss per share in Q2 carries into a third quarter, and whether revenue keeps growing from one quarter to the next.

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q2 2026Aug 10, 2026−$0.31−$0.22+28.55%$29.4MSEC
Q1 2026May 8, 2026−$1.71−$1.74−1.75%$26.0MSEC

Quarterly revenue

Q1 2026
$26.0M
Q2 2026
$29.4M

Frequently asked questions

  • When did Alamar Biosciences (ALMR) last report earnings?

    Alamar Biosciences last reported on Aug 10, 2026, covering fiscal Q2 2026.

  • Did ALMR beat earnings estimates?

    Yes. Alamar Biosciences reported EPS of −$0.22 for Q2 2026 against a −$0.31 estimate — a 28.55% beat.

  • How much revenue did ALMR report last quarter?

    Alamar Biosciences reported $29.4M in revenue for Q2 2026, against a consensus estimate of $25.9M.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.